Tenon Medical Inc TNON.OQ reported a quarterly adjusted loss of 36 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-8.16. The mean expectation of two analysts for the quarter was for a loss of 47 cents per share.
Revenue fell 37.4% to $564.00 thousand from a year ago; analysts expected $909.50 thousand.
Tenon Medical Inc's reported EPS for the quarter was a loss of 36 cents.
The company reported a quarterly loss of $2.77 million.
Tenon Medical Inc shares had risen by 50.4% this quarter and lost 21.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Tenon Medical Inc is $3.00, about 51% above its last closing price of $1.47
This summary was machine generated from LSEG data August 13 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | -0.47 | -0.36 | Beat |
Mar. 31 2025 | -1.11 | -1.01 | Beat |
Dec. 31 2024 | -2.54 | -2.54 | Met |
Sep. 30 2024 | -4.23 | -3.63 | Beat |